{"entity":{"type":"insider","cik":"0001598542","url":"/insider/0001598542","json_url":"/insider/0001598542.json","name":"Carroll Jill","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2014-04-01","last":"2026-05-01","span_basis":"filed_date"},"name_variants":[{"name":"Carroll Jill","source":"filing","n_filings":8,"first_seen":"2014-04-01","last_seen":"2026-05-01"}],"transactions":[{"id":5749400,"accession":"0001193125-26-201894","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-201894","line_url":"/filing/0001193125-26-201894#line-3","is_derivative":false,"issuer_cik":"0001540171","issuer_name":"Avalyn Pharma Inc.","issuer_ticker":"AVLN","issuer_name_source":null,"issuer_url":"/issuer/0001540171","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277778.0,"shares_display":"277,778","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5000004.0,"total_display":"5,000,004.00","total_whole":"5,000,004","shares_owned_after":2186562.0,"shares_owned_after_display":"2,186,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider"},{"id":2459807,"accession":"0000950170-24-036013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-036013","line_url":"/filing/0000950170-24-036013#line-1","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504263.0,"shares_display":"504,263","price_per_share":70.55,"price_display":"70.55","price_state":"stated","total_value":35575754.65,"total_display":"35,575,754.65","total_whole":"35,575,755","shares_owned_after":1479148.0,"shares_owned_after_display":"1,479,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-25","scope":"insider"},{"id":8374378,"accession":"0001209191-23-058974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058974","line_url":"/filing/0001209191-23-058974#line-1","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504263.0,"shares_display":"504,263","price_per_share":49.13,"price_display":"49.13","price_state":"stated","total_value":24774441.19,"total_display":"24,774,441.19","total_whole":"24,774,441","shares_owned_after":1983411.0,"shares_owned_after_display":"1,983,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":8333408,"accession":"0001209191-23-033867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033867","line_url":"/filing/0001209191-23-033867#line-2","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25556.0,"shares_display":"25,556","price_per_share":44.3464,"price_display":"44.35","price_state":"stated","total_value":1133316.5984,"total_display":"1,133,316.60","total_whole":"1,133,317","shares_owned_after":2487674.0,"shares_owned_after_display":"2,487,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8333404,"accession":"0001209191-23-033867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033867","line_url":"/filing/0001209191-23-033867#line-1","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":315164.0,"shares_display":"315,164","price_per_share":41.5,"price_display":"41.50","price_state":"stated","total_value":13079306.0,"total_display":"13,079,306.00","total_whole":"13,079,306","shares_owned_after":2513230.0,"shares_owned_after_display":"2,513,230","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":8153519,"accession":"0001209191-23-029613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029613","line_url":"/filing/0001209191-23-029613","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":638417.0,"shares_display":"638,417","price_per_share":45.01168162815213,"price_display":"45.01","price_state":"stated","total_value":28736222.75,"total_display":"28,736,222.75","total_whole":"28,736,223","shares_owned_after":2834879.0,"shares_owned_after_display":"2,834,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider","n_lines":2},{"id":6777131,"accession":"0001209191-22-008157","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-008157","line_url":"/filing/0001209191-22-008157","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666667.0,"shares_display":"1,666,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":25000005.0,"total_display":"25,000,005.00","total_whole":"25,000,005","shares_owned_after":2033196.0,"shares_owned_after_display":"2,033,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":3161852,"accession":"0000899243-20-019891","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019891","line_url":"/filing/0000899243-20-019891#line-3","is_derivative":false,"issuer_cik":"0001598542","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001598542","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":361111.0,"shares_display":"361,111","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":6499998.0,"total_display":"6,499,998.00","total_whole":"6,499,998","shares_owned_after":2248304.0,"shares_owned_after_display":"2,248,304","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider"},{"id":7033533,"accession":"0001209191-14-024135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-024135","line_url":"/filing/0001209191-14-024135#line-2","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001598542","owner_name":"Carroll Jill","owner_display_name":"Carroll Jill","owner_url":"/insider/0001598542","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103762.0,"shares_display":"103,762","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1245144.0,"total_display":"1,245,144.00","total_whole":"1,245,144","shares_owned_after":1989598.0,"shares_owned_after_display":"1,989,598","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001540171","name":"Avalyn Pharma Inc.","url":"/issuer/0001540171","role":"Director","n_filings":1,"first_seen":"2026-05-01","last_seen":"2026-05-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Director","n_filings":5,"first_seen":"2022-02-09","last_seen":"2024-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-04-01","last_seen":"2014-04-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598542","retrieved_at":"2026-08-23T18:42:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}